mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
UNC0638 |
GDSC1000 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.2 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.2 |